MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TG Therapeutics (TGTX) Ownership - Who owns TG Therapeutics?

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.79B
P/E Ratio
13.09
Total Cash
141.97M
Projected Growth
N/A
Total Debt
253.71M
Revenue
616.29M
Risk (Beta)
1.82
Dividend Yield
N/A
Total Cash/Share
0.89
Total Debt/Equity
0.21
Revenue/Share
3.82 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TGTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TGTX showed earnings on February 26, 2026. You can read more about the earnings report here.
View AI-Driven Trading for TGTX
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com